FDA establishment 3011640199, Shijiazhuang, China. Part of Yiling Pharmaceutical's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| Oct 11, 2024 | Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Jun 15, 2018 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Product | Charges | Latest |
|---|---|---|
| VALSARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62ODA12 | Oct 20, 20252 lines |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports
Shijiazhuang, China. Part of